Clinical Trials Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Apr 14, 2017; 23(14): 2601-2612
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2601
Table 3 Relationship of ROR2 and WNT5a expression with the clinicopathologic characteristics of gallbladder adenocarcinomas n (%)
Pathologic characteristicNumber of casesROR2
WNT5a
Positive casesχ2P valuePositive casesχ2P value
Differentiation
High2712 (44.0)10.3520.00211 (40.7)8.4040.015
Moderate2515 (60.0)16 (64.0)
Poor2824 (85.7)22 (78.6)
Maximal diameter of the mass in cm
≤ 35026 (52.0)7.9660.00426 (52.0)4.8070.029
> 33025 (83.3)23 (76.7)
Gallstones
No4226 (61.9)0.130.71826 (61.9)0.0160.899
Yes3825 (65.8)23 (60.5)
TNM stage
I + II217 (33.3)7 (33.3)
III3825 (65.8)14.968024 (63.2)12.2480.002
IV2119 (90.5)18 (85.7)
Lymph node metastasis
No3012 (40.0)11.7160.00112 (40.0)9.1320.003
Yes5039 (78.0)37 (74.0)
Invasion of the surrounding tissue
No3113 (41.9)10.4220.00212 (38.7)10.8340.001
Yes4938 (77.6)37 (75.5)
Surgical procedure
Radical2610 (38.5)12.2960.00210 (38.5)11.680.003
Palliative2819 (67.9)17 (60.7)
Unresected2622 (84.6)22 (84.6)